Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erelzi lyophilized powder versus US-licensed Enbrel in healthy male volunteers
NL-OMON45782Active, not recruiting
- Sponsor
- Hexal AG
- Start
- Jun 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of etanercept in rheumatoid arthritis (RA) (2 arms), sponsored by Hexal AG. Primary endpoint: Pharmacokinetic similarity. Started Jun 2019; status: active, not recruiting.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON45782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45782.